Editas Medicine, Inc. (EDIT)

Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	138.54	131.54	123.65	141.52	203.52	139.68
Short-Term Investments	39.96	138.37	199.46	202.75	296.33	262.43
Cash & Short-Term Investments	178.5	269.91	323.11	344.27	499.85	402.11
Cash Growth	-36.05%	-16.46%	-6.15%	-31.12%	24.31%	-12.04%
Accounts Receivable	0.59	16.27	10.19	5.15	0.27	6.05
Receivables	0.59	16.27	10.19	5.15	0.27	6.05
Prepaid Expenses	3.71	3.14	7.53	7.34	7.2	10.93
Total Current Assets	182.8	289.32	340.83	356.75	507.31	419.09
Property, Plant & Equipment	23.59	47.05	45.71	59.22	43.29	39.15
Long-Term Investments	-	-	104.02	93.1	120.07	109.66
Other Long-Term Assets	4.2	5.22	8.59	5.25	6.81	4.7
Total Assets	210.58	341.59	499.15	514.32	677.48	572.6
Accounts Payable	6.72	5.49	8.27	9.51	5.05	6.41
Accrued Expenses	14.33	44.1	34.56	31.3	20.19	24.05
Current Portion of Leases	6.15	14.65	12.16	11.08	10.31	6.81
Current Unearned Revenue	5	11.22	8.22	8.22	11.33	20.94
Other Current Liabilities	33.74	1.76	-	-	-	-
Total Current Liabilities	65.94	77.23	63.22	60.11	46.88	58.21
Long-Term Leases	14.99	20.38	24.37	32.86	16.07	19.32
Long-Term Unearned Revenue	105.87	106.64	60.67	60.67	60.89	73.98
Other Long-Term Liabilities	4.59	3.07	1.8	-	-	27.5
Total Liabilities	191.39	207.32	150.06	153.64	123.84	179.02
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,617	1,602	1,580	1,442	1,412	1,059
Retained Earnings	-1,598	-1,468	-1,231	-1,078	-857.7	-665.2
Comprehensive Income & Other	0.02	0.27	0.2	-3.6	-0.49	-0.05
Total Common Equity	19.19	134.27	349.1	360.68	553.64	393.59
Shareholders' Equity	19.19	134.27	349.1	360.68	553.64	393.59
Total Liabilities & Equity	210.58	341.59	499.15	514.32	677.48	572.6
Total Debt	21.14	35.03	36.54	43.95	26.38	26.14
Net Cash (Debt)	157.37	234.88	390.6	393.43	593.54	485.64
Net Cash Growth	-43.72%	-39.87%	-0.72%	-33.72%	22.22%	13.45%
Net Cash Per Share	1.89	2.85	5.14	5.73	8.78	8.29
Filing Date Shares Outstanding	89.92	82.98	81.81	67.47	68.46	67.24
Total Common Shares Outstanding	87.39	82.73	81.77	67.35	68.44	62.56
Working Capital	116.86	212.09	277.61	296.64	460.43	360.88
Book Value Per Share	0.22	1.62	4.27	5.36	8.09	6.29
Tangible Book Value	19.19	134.27	349.1	360.68	553.64	393.59
Tangible Book Value Per Share	0.22	1.62	4.27	5.36	8.09	6.29
Machinery	22.66	30.88	26.37	25.55	22.72	19.17
Construction In Progress	-	0.83	2.06	1.57	1.53	0.86
Leasehold Improvements	8.4	11.75	9.65	9.76	8.16	4.97

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q